The IVth workshop on Duchenne muscular dystrophy gene therapy.
Schwartz
K
K
Inserm U523, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. s.tary@myologie.chups.jussieu.fr
Leterrier
F
F
D000256:Adenoviridae / Q000235:genetics; D000293:Adolescent; D000328:Adult; D000818:Animals; D017690:Cell Transplantation; D002648:Child; D002986:Clinical Trials as Topic; D006224:Cricetinae; D003598:Cytoskeletal Proteins / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics; D000229:Dependovirus / Q000235:genetics; D004195:Disease Models, Animal; D018274:Electroporation; D004738:Engineering; D005260:Female; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000276:immunology / Q000627:therapeutic use; D006085:Graft Survival; D000882:Haplorhini; D006292:Health Priorities; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000172:deficiency / Q000235:genetics; D008565:Membrane Proteins / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D018101:Mice, Inbred mdx; D018345:Mice, Knockout; D016513:Mice, SCID; D009000:Monocytes / Q000637:transplantation / Q000821:virology; D018482:Muscle, Skeletal / Q000166:cytology / Q000473:pathology / Q000821:virology; D009136:Muscular Dystrophies / Q000145:classification / Q000235:genetics / Q000628:therapy*; D009137:Muscular Dystrophy, Animal / Q000235:genetics / Q000628:therapy; D009206:Myocardium / Q000473:pathology; D051381:Rats; D049031:Sarcoglycans; D049411:Utrophin
D003598:Cytoskeletal Proteins; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D049031:Sarcoglycans; C483600:Utrn protein, mouse; D049411:Utrophin